NRC Health
NRC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000070487
No open-market purchases or sales by NRC Health insiders were filed in the last 90 days; 123 institutions reported holding it in 13F filings for Q2 2026, worth $231.9M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +5 vs. previous quarter
- 123
- 13F valueReported value at the end of Q2 2026
- $231.9M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NRC, Q2 2026
No superinvestor reported holding NRC at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by NRC Health insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Harrison Shane REVP & Chief Financial Officer | PPurchase | +8.00K | $12.27 | +$98.2K | New position8.00K after | |
| Aug 4, 2025 (view filing) | Jul 31 | 4 days | Freeman Jordan NicoleChief Accounting Officer | PPurchase | +771 | $12.97 | +$10.0K | New position771 after | |
| May 13, 2025 (view filing) | May 12 | 1 day | Beans Patrick E10% Owner | PPurchase | +2.50K | $13.59 | +$34.0K | +7.7%35.0K after | |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Common Property Trust10% Owner | SSale | −598.7K | $40.54 | −$24.3M | −13.4%3.85M after | |
| Jan 8, 2024 (view filing) | Jan 4-5 | 4 days | Amandla MK Trust10% Owner | SSale | −7.21K | $40.85 | −$294.7K | −0.2%3.83M after | 2 lots |
| Jan 5, 2024 (view filing) | Jan 3 | 2 days | Common Property Trust10% Owner | SSale | −364.6K | $41.53 | −$15.1M | −7.6%4.45M after | |
| Jan 4, 2024 (view filing) | Jan 2-3 | 2 days | Amandla MK Trust10% Owner | SSale | −321.2K | $40.86 | −$13.1M | −7.7%3.84M after | 3 lots |
| Dec 14, 2023 (view filing) | Dec 12-14 | 2 days | Amandla MK Trust10% Owner | SSale | −26.3K | $41.55 | −$1.09M | −0.6%4.16M after | 3 lots |
| Dec 11, 2023 (view filing) | Dec 7-11 | 4 days | Amandla MK Trust10% Owner | SSale | −54.7K | $41.56 | −$2.27M | −1.3%4.19M after | 3 lots |
| Dec 6, 2023 (view filing) | Dec 4-6 | 2 days | Amandla MK Trust10% Owner | SSale | −2.55K | $41.60 | −$106.1K | −0.1%4.24M after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in NRC Health at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 2,030,492 | $43.8M | 0.14% | −605,863−23.0% | Reduced |
| BlackRock, Inc. | 1,061,355 | $22.9M | 0.00% | +85,500+8.8% | Added |
| Morgan Stanley | 859,269 | $18.5M | 0.00% | −142,611−14.2% | Reduced |
| Vanguard Capital Management LLC | 666,554 | $14.4M | 0.00% | +3,717+0.6% | Added |
| Dimensional Fund Advisors LP | 491,228 | $10.6M | 0.00% | +1,488+0.3% | Added |
| Willis Investment Counsel | 434,785 | $9.38M | 0.45% | +210,147+93.5% | Added |
| Geode Capital Management, LLC | 420,056 | $9.06M | 0.00% | +26,209+6.7% | Added |
| QV Investors Inc. | 372,503 | $8.04M | 0.62% | −8,807−2.3% | Reduced |
| Farmers & Merchants Investments Inc | 330,649 | $7.13M | 0.17% | +330,549+330,549.0% | Added |
| Renaissance Technologies LLC | 325,384 | $7.02M | 0.01% | −15,400−4.5% | Reduced |